Skip to main content
. 2020 Jun 24;58(7):e00343-20. doi: 10.1128/JCM.00343-20

TABLE 2.

BFPP performance summary for BAL-type and sputum-type specimens

Analytec PPA
NPA
BFPP-pos SOC-NTb
BFPP-neg SOC-NT
Prop.a % 95% CId (%) Prop. % 95% CId (%)
Viruses
    Rhinovirus/enterovirus 5/5 100 56.6–100 103/103 100 96.4–100 4 88
    Influenza A virus 4/5 80 37.6–99.0 104/105 99.0 94.8–99.9 1 89
    Coronavirus 1/3 33.3 1.7–88.2 106/107 99.1 94.9–99.9 1 91
    Influenza B virus 3/3 100 43.9–100 107/107 100 96.5–100 1 89
    RSV 4/4 100 51.0–100 106/106 100 96.5–100 0 90
    Metapneumovirus 1/1 100 5.1–100 107/107 100 96.5–100 2 90
    Parainfluenza virus 1/1 100 5.1–100 106/107 99.1 94.9–99.9 0 92
    Adenovirus 0/1 0 0–94.9 107/107 100 96.5–100 0 92
        Total 19/23 82.6 62.9–93.0 846/849 99.5 99.0–99.9 9 721
Bacteria
    Staphylococcus aureus 22/22 100 85.1–100 156/178 87.6 82.0–91.7 0 0
    Haemophilus influenzae 3/3 100 43.9–100 172/197 87.3 81.9–91.3 0 0
    Pseudomonas aeruginosa 8/8 100 67.6–100 185/192 96.4 92.7–98.2 0 0
    Enterobacter cloacae complex 3/4 75 30.1–98.7 189/196 96.4 92.8–98.3 0 0
    Escherichia coli 6/6 100 61.0–100 190/194 97.9 94.8–99.2 0 0
    Streptococcus pneumoniae 2/2 100 17.8–100 191/198 96.5 92.9–98.3 0 0
    Klebsiella pneumoniae group 4/4 100 51.0–100 192/196 98.0 94.9–99.2 0 0
    Streptococcus agalactiae 2/2 100 17.8–100 193/198 97.5 94.2–98.9 0 0
    Klebsiella aerogenes 2/2 100 17.8–100 196/198 99.0 96.4–99.8 0 0
    Klebsiella oxytoca 3/3 100 43.9–100 196/197 99.5 97.2–99.9 0 0
    Moraxella catarrhalis 1/1 100 5.1–100 196/199 98.5 95.7–99.6 0 0
    Proteus spp. 0/0 NAe NA 196/200 98.0 95.0–99.2 0 0
    Serratia marcescens 3/3 100 43.9–100 197/197 100 98.1–100 0 0
    Acinetobacter baumanniicalcoaceticus complex 0/0 NA NA 199/200 99.5 97.2–99.9 0 0
    Legionella pneumophila 0/0 NA NA 44/44 100 92.0–100 1 156
    Mycoplasma pneumoniae 1/1 100 5.1–100 86/86 100 95.7–100 0 80
        Total 60/61 98.4 91.3–99.9 2778/2870 96.8 96.1–97.4 1 236
a

Prop., proportion for positive percent agreement (PPA) or negative percent agreement (NPA), calculated as follows: PPA = concordant positive/all positive results by SOC, and NPA = concordant negative/all negative results by SOC.

b

BFPP-pos, SOC-NT, analyte detected by BFPP but not tested by standard of care.

c

SOC testing also detected herpes simplex virus (n = 5), cytomegalovirus (n = 4), Stenotrophomonas maltophilia (n = 4), Acinetobacter spp. (n = 1), Citrobacter freundii complex (n = 1), Klebsiella variicola (n = 1), and Staphylococcus intermedius group (n = 1), which are not included in the BFPP panel. SOC testing detected yeast or mold in an additional 26 samples, including 21 yeasts, 2 Aspergillus spp., 1 Blastomyces dermatitidis/B. gilchristii isolate, 1 Paecilomyces species, and 1 Pneumocystis jirovecii isolate.

d

CI, confidence agreement for a binomial distribution, calculated by the Wilson/Brown method.

e

NA, not applicable.